头颈部鳞状细胞癌患者下颌骨放射性骨坏死危险因素
该回顾性研究纳入2008-2018年接受根治性或术后放疗的616例头颈部鳞状细胞癌患者,评估与下颌骨放射性骨坏死(ORNJ)相关的因素,重点分析下颌骨剂量体积直方图参数。多因素分析显示V60>14%和原发肿瘤部位(口咽或口腔癌)是ORNJ的独立危险因素。
要点
- V60>14%是ORNJ独立危险因素(p=0.0065)。
- 口咽或口腔癌患者ORNJ风险显著高于其他部位(p<0.0001)。
- V60≤14%与>14%患者3年累积ORNJ发生率分别为2.5%和8.6%。
核心结论
- V60>14%和口咽或口腔癌是头颈部鳞状细胞癌根治性放疗后ORNJ的独立危险因素。
研究设计与样本
- 回顾性队列研究,纳入2008-2018年接受根治性或术后放疗的616例头颈部鳞状细胞癌患者。
主要发现
- ORNJ患者V30-V70值显著高于无ORNJ患者。
- 单因素分析中,原发肿瘤部位、放疗前下颌骨手术、放疗后拔牙和V60>14%为重要因素。
- 多因素分析中V60>14%(p=0.0065)和原发肿瘤部位(p=0.0059)保持显著。
- V60≤14%与>14%患者3年累积ORNJ发生率分别为2.5%和8.6%(p<0.0001);口咽或口腔癌与其他癌症分别为9.3%和1.4%(p<0.0001)。
关键数值与推荐
- V60>14%定义为下颌骨接受≥60 Gy的相对体积超过14%。
- 口咽或口腔癌原发部位为ORNJ独立危险因素。
临床怎么用
- 在头颈部鳞状细胞癌根治性放疗计划中,应关注下颌骨V60,尽量将其控制在14%以下以降低ORNJ风险。
- 对口咽或口腔癌患者应加强ORNJ监测与预防。
局限性
- 回顾性研究设计。
- 单中心数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate factors associated with osteoradionecrosis of the jaw (ORNJ) in patients with head and neck squamous cell carcinoma (HNSCC), focusing on jaw-related dose-volume histogram (DVH) parameters. METHODS: We retrospectively reviewed the medical records of 616 patients with HNSCC treated with curative-intent or postoperative radiation therapy (RT) during 2008-2018. Patient-related (age, sex, history of smoking or alcohol use, diabetes mellitus, performance status, pre-RT dental evaluation, pre- or post-RT tooth extraction), tumor-related (primary tumor site, T-stage, nodal status), and treatment-related (pre-RT surgery, pre-RT mandible surgery, induction or concurrent chemotherapy, RT technique) variables and DVH parameters (relative volumes of the jaw exposed to doses of 10 Gy-70 Gy [V10-70]) were investigated and compared between patients with and without ORNJ. The Mann-Whitney U test was used to compare RT dose parameters. Univariate and multivariate Cox regression analyses were used to assess factors associated with ORNJ development. Kaplan-Meier analyses were performed for cumulative ORNJ incidence estimation. RESULTS: Forty-six patients (7.5%) developed ORNJ. The median follow-up duration was 40 (range 3-145) months. The median time to ORNJ development was 27 (range 2-127) months. DVH analysis revealed that V30-V70 values were significantly higher in patients with than in those without ORNJ. In univariate analyses, primary tumor site, pre-RT mandible surgery, post-RT tooth extraction, and V60 > 14% were identified as important factors. In multivariate analyses, V60 > 14% (p = 0.0065) and primary tumor site (p = 0.0059) remained significant. The 3-year cumulative ORNJ incidence rates were 2.5% and 8.6% in patients with V60 ≤ 14% and > 14%, respectively (p < 0.0001), and 9.3% and 1.4% in patients with oropharyngeal or oral cancer and other cancers, respectively (p < 0.0001). CONCLUSIONS: V60 > 14% and oropharyngeal or oral cancer were found to be independent risk factors for ORNJ. These findings might be useful to minimize ORNJ incidence in HNSCC treated with curative RT.
引用
- Kubota H, Miyawaki D, Mukumoto N, et al. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. 2021. PMID: 33402192. doi:10.1186/s13014-020-01701-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。